Skip to main content
. 2022 Jul 15;13(7):521–531. doi: 10.4239/wjd.v13.i7.521

Table 2.

Descriptive statistics of main variables analyzed in individuals of group 2 (bisphenol S)

BPS quartile
Q1
Q2
Q3
Q4
n 915 911 894 938
Age 42.88 (41.65-44.14) 42.42 (41.22-43.65) 44.5 (43.32-45.72) 45.8 (43.89-46.3)d
Gender, % of men 56.3 49.7 42.8 40.6
BMI, kg/m2 27.76 (27.36-28.17) 28.41 (27.99-28.83) 28.94 (28.51-29.38)c 28.57 (28.15-29)a
Diabetes mellitus, % 15.3 16.6 18.1 20
Fasting glucose, mg/dL 103.7 (101.8-105.8) 104.5 (102.4-106.6) 108.2 (105.5-111) 108.8 (106.3-111.5)a
HbA1c, % 5.62 (5.57-5.68) 5.66 (5.61-5.72) 5.75 (5.69-5.81) 5.78 (5.71-5.85)
Smoker, % 43.6 44.8 42.4 44.5
Cotinine, serum, ng/mL 0.24 (0.19-0.32) 0.27 (0.21-0.35) 0.24 (0.18-0.31) 0.27 (0.21-0.35)
Hypertension, % 39 40.6 43.4 46.3
Systolic blood pressure, mmHg 120.6 (119.5-121.7) 123.1 (122-124.2) 122.5 (121.4-123.7) 123.9 (122.7-125.1)
Diastolic blood pressure, mmHg 68.31 (67.5-69.13) 69.36 (68.52-70.21) 69.18 (68.37-69.99) 68.18 (67.37-69)
Dyslipidemia, % 39.3 40.6 40.8 41.5
Total cholesterol, mg/dL 184.3 (131.6-187) 184.7 (182-187.3) 187.7 (184.9-190.5) 188.3 (185.7-190. 9)
Bisphenol F, µg/g creatinine 0.37 (0.34-0.41) 0.43 (0.39-0.47)a 0.41 (0.38-0.45) 0.45 (0.41-0.49)b
a

P < 0.05, significant differences with respect to group Q1.

b

P < 0.01, significant differences with respect to group Q1.

c

P < 0.001, significant differences with respect to group Q1.

d

P < 0.05, significant differences between Q2 and Q4.

The results are expressed as percentages (%) or as geometric mean (95%CI). BMI: Body mass index; HbA1c: Hemoglobin A1c; BPS: Bisphenol S; BPF: Bisphenol F.